A pharmacological master key mechanism that unlocks the selectivity filter gate in K<sup>+</sup> channels.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30792303.
- Also identified by DOI 10.1126/science.aav0569 and PMC identifier 6982535.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Potassium (K<sup>+</sup>) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K<sup>+</sup> channels gated at their selectivity filter (SF), including many two-pore domain K<sup>+</sup> (K<sub>2P</sub>) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca<sup>2+</sup>)-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K<sup>+</sup> occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K<sup>+</sup> channel activators and highlight a filter gating machinery that is conserved across different families of K<sup>+</sup> channels with implications for rational drug design.
Medical subject headings
- Chlorobenzenes
- ERG1 Potassium Channel
- Ion Channel Gating
- Large-Conductance Calcium-Activated Potassium Channels
- Tetrahydronaphthalenes
- Tetrazoles
- Thiourea
- ortho-Aminobenzoates